Inspire Medical Systems, Inc. $INSP Shares Purchased by LPL Financial LLC

LPL Financial LLC increased its holdings in shares of Inspire Medical Systems, Inc. (NYSE:INSP) by 3.2% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 10,126 shares of the company’s stock after purchasing an additional 315 shares during the quarter. LPL Financial LLC’s holdings in Inspire Medical Systems were worth $1,613,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. True Wealth Design LLC boosted its holdings in Inspire Medical Systems by 39.0% during the 4th quarter. True Wealth Design LLC now owns 196 shares of the company’s stock valued at $36,000 after acquiring an additional 55 shares during the period. Captrust Financial Advisors boosted its holdings in Inspire Medical Systems by 2.0% during the 4th quarter. Captrust Financial Advisors now owns 3,034 shares of the company’s stock valued at $562,000 after acquiring an additional 59 shares during the period. MML Investors Services LLC boosted its holdings in Inspire Medical Systems by 0.9% during the 4th quarter. MML Investors Services LLC now owns 7,941 shares of the company’s stock valued at $1,472,000 after acquiring an additional 67 shares during the period. Mariner LLC boosted its holdings in Inspire Medical Systems by 1.6% during the 4th quarter. Mariner LLC now owns 4,837 shares of the company’s stock valued at $897,000 after acquiring an additional 77 shares during the period. Finally, Allianz Asset Management GmbH boosted its holdings in Inspire Medical Systems by 1.6% during the 1st quarter. Allianz Asset Management GmbH now owns 5,000 shares of the company’s stock valued at $796,000 after acquiring an additional 78 shares during the period. 94.91% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the company. UBS Group set a $230.00 price objective on Inspire Medical Systems and gave the company a “buy” rating in a research note on Tuesday, August 5th. Wells Fargo & Company decreased their price objective on Inspire Medical Systems from $174.00 to $101.00 and set an “equal weight” rating for the company in a research note on Tuesday, August 5th. Piper Sandler decreased their price objective on Inspire Medical Systems from $233.00 to $150.00 and set an “overweight” rating for the company in a research note on Tuesday, August 5th. Lake Street Capital set a $150.00 price objective on Inspire Medical Systems and gave the company a “buy” rating in a research note on Tuesday, August 5th. Finally, Wall Street Zen cut Inspire Medical Systems from a “buy” rating to a “hold” rating in a research note on Saturday, July 26th. Seven research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $165.62.

Inspire Medical Systems Trading Down 1.4%

Shares of NYSE INSP opened at $91.7640 on Friday. Inspire Medical Systems, Inc. has a twelve month low of $73.92 and a twelve month high of $225.00. The stock has a 50 day moving average of $118.18 and a two-hundred day moving average of $145.50. The stock has a market cap of $2.71 billion, a P/E ratio of 53.04, a P/E/G ratio of 2.90 and a beta of 1.22.

Inspire Medical Systems (NYSE:INSP) last issued its quarterly earnings data on Monday, August 4th. The company reported $0.45 earnings per share for the quarter, beating analysts’ consensus estimates of $0.22 by $0.23. Inspire Medical Systems had a return on equity of 10.38% and a net margin of 6.17%.The company had revenue of $217.09 million during the quarter, compared to analysts’ expectations of $214.50 million. During the same quarter in the previous year, the business earned $0.32 earnings per share. The firm’s revenue for the quarter was up 10.8% on a year-over-year basis. Inspire Medical Systems has set its FY 2025 guidance at 0.400-0.500 EPS. As a group, research analysts predict that Inspire Medical Systems, Inc. will post 2.16 earnings per share for the current year.

Inspire Medical Systems declared that its Board of Directors has authorized a share buyback program on Monday, August 11th that allows the company to buyback $200.00 million in outstanding shares. This buyback authorization allows the company to buy up to 8.6% of its shares through open market purchases. Shares buyback programs are typically a sign that the company’s board of directors believes its stock is undervalued.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.